["{\"step_by_step_thinking\": \"The relevant documents provided information on cancer survival rates for different age groups and patient populations. However, there is no specific mention of tremelimumab, which is a monoclonal antibody used to treat mesothelioma. Therefore, it's not possible to determine whether tremelimumab improves survival of mesothelioma patients based on the provided documents.\", \"answer_choice\": B}"]